Of the tracked stories, 8 of 20 also mention Weiss Ratings, the most common co-covered peer. The 148-day window averages about 0.9 stories each week. The busiest single day carried 3. Coverage clusters in markets, which accounts for 11 of those 20, with the remainder spread across 6 other categories.
Coverage balanceBalanced directional read. Positive and negative coverage are within 5 percentage points.
10% positive
85% neutral
5% negative
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about TD Cowen
Of the tracked stories, 8 of 20 also mention Weiss Ratings, the most common co-covered peer. The 148-day window averages about 0.9 stories each week. The busiest single day carried 3. Coverage clusters in markets, which accounts for 11 of those 20, with the remainder spread across 6 other categories. Each carries 2.1 original sources on average. Negative sentiment appears in 5% of the tracked stories. We currently track 20 Cross-Sector stories that mention TD Cowen, published between March 24, 2026 and August 18, 2026.
Stories tracked
20
Per week
0.9
Negative
5%
Sources per story
2.1
Computed from the 20 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering TD Cowen. Shared-story counts are live from our verified record — not editorial picks.
Wall Street Zen cut both Klaviyo and Oceaneering International from Buy to Hold in Saturday research notes.
Citigroup lifts KVYO target
Citigroup raised its Klaviyo price target from $34.00 to $36.00 with a Buy rating.
KVYO analyst revisions
Stephens, BTIG, Stifel, and Truist adjusted price targets on Klaviyo following earnings.
Klaviyo Q2 earnings
Klaviyo reported EPS of $0.19, meeting consensus, and revenue of $370.58 million.
OII insider sale
SVP Christopher J. Dyer sold 1,200 OII shares at an average price of $47.65 for $57,180.
Weiss upgrades OII
Weiss Ratings raised OII from Buy (B-) to Buy (B).
Barclays lifts OII target
Barclays increased its OII price objective from $39.00 to $47.00 with an Equal Weight rating.
Wells Fargo Cuts Target to $70
Wells Fargo & Company lowers Freshpet’s price target from $75.00 to $70.00, keeping an Overweight rating, implying 28.42% upside.
Bank of America Lowers Target
Bank of America reduces its price target from $75.00 to $70.00 and maintains a Neutral rating.
TD Cowen Sets Street-High $73 Target
TD Cowen raised target from $63 to $73, the highest among all analysts, maintaining a Buy rating.
Citigroup raises OII target
Citigroup raised its Oceaneering target from $35.00 to $40.00 with a Neutral rating.
Piper Sandler Stays Overweight
Piper Sandler reaffirms an Overweight rating on Freshpet shares.
Weiss Ratings Downgrades
Weiss Ratings cuts Freshpet from 'Hold (c)' to 'Hold (c-)'.
Morgan Stanley Revises Target to $51
Morgan Stanley raised target from $38 to $51 but kept Equal Weight rating, signaling a cautious stance.
Analyst Surge: Four Firms Raise Targets
Oppenheimer, Goldman Sachs, KeyCorp, and Barclays all lifted price targets to the $55–$60 range, reiterating Buy/Outperform ratings.
JPMorgan Upgrades, Others Reaffirm
JPMorgan raises rating from Neutral to Overweight and lifts target from $66.00 to $68.00. Morgan Stanley reiterates Overweight with $77.00 target, while Deutsche Bank holds at Hold with $63.00 target.
TD Cowen lifts OII target
TD Cowen raised its Oceaneering International price target from $34.00 to $36.00 with a Hold rating.
Jefferies Cuts Target
Jefferies Financial Group lowers its price objective from $75.00 to $70.00 and maintains a Hold rating.
TD Cowen Turns Bullish
TD Cowen upgrades Freshpet from Hold to Buy and sets an $80.00 price objective.
Market Outperformance
Grail shares end the week as a top performer in the healthcare sector, recouping major losses.
A late-stage trial found Amylyx's once-daily injection avexitide reduced hypoglycemic episodes by 55% in people with post-bariatric hypoglycemia, a condition with no approved treatments. The drug was well tolerated, and the company plans a U.S. filing by end of 2026. For health systems and clinicians, the result signals a potential first-ever standard therapy that could change post-bariatric care.
CORDA Investment Management initiated a new $1.4 million position in Enterprise Products Partners during Q2 2026, joining other institutional buyers as total institutional ownership reached 26.07%. Mixed ratings from Morgan Stanley, Goldman Sachs, and TD Cowen reflect an unresolved debate over valuation and growth. The accumulation signals cautious but growing institutional appetite for midstream energy income.
SaaS and cloud operators are watching Klaviyo as a high-multiple vertical SaaS proxy. Wall Street Zen's Buy-to-Hold cut, after Q2 revenue of $370.58 million and EPS in line, shows how quickly a premium valuation can compress when growth doesn't exceed expectations.
Marketing and AdTech teams relying on Klaviyo face new investor scrutiny after Wall Street Zen cut the stock to Hold despite Q2 revenue of $370.58 million and in-line EPS of $0.19. The downgrade lands as analyst targets diverge while the company trades at a 895.95 P/E, raising questions about martech spending sustainability.
Wall Street Zen downgraded both Oceaneering International and Klaviyo from Buy to Hold, spotlighting two $5 billion market-cap companies with vastly different P/E ratios—14.59 for OII and 895.95 for KVYO. The ratings actions come as consensus targets diverge from current prices.
SoFi Technologies shares jumped 3.7% on August 4, 2026, even as multiple analysts slashed price targets, creating a tension between market momentum and cautious research. With a PE of 38.96, beta of 2.17, and consensus Hold rating, the fintech’s next move hinges on whether profitability can catch up with valuation.
Wells Fargo lowered Check Point's target to $130, highlighting a divided analyst community with an average target of $149.48. The stock's depressed valuation and low beta present a potential value opportunity against high-growth cyber peers.
Benchmark boosted outlooks on two disparate stocks—First Internet Bancorp and DexCom—offering a stark contrast in risk/reward. While INBK promises 21.74% upside based on the new $35 target, DXCM’s $82 target sits slightly below its trading price, highlighting valuation concerns despite a Buy rating.
Jim Cramer attributes Amazon’s recent stock movement to a market rotation into hyperscaler stocks, while Prime Day sell-through data signals accelerating e-commerce demand. With Bank of America and TD Cowen issuing bullish notes, the retail and cloud giant is positioned for a strong Q2, potentially hitting $200B in revenue.
Astronics Corporation's stock jumped 7.8% amid a series of analyst upgrades and an impending 6-for-5 stock split. As a key supplier to both commercial aerospace and defense programs, the move reflects growing confidence in the space and defense sector. The company's strong liquidity and new product lines position it for further gains in avionics and lighting.
Astronics Corporation's share price vaulted 7.8% on June 11, 2026, to $88.76, with analysts split between a $100 high target and a sell rating. The company's 6-for-5 stock split, effective June 15, adds to the excitement, but low volume and high P/E warrant caution for value investors.
Needham & Company’s reasserted Buy rating on ServiceTitan, with a $100 price target, underscores the growing confidence in cloud-based platforms that digitize home and commercial service trades. For PropTech investors, the move highlights how essential service management software is becoming within the real estate ecosystem.
Morgan Stanley lowered its BlackRock (BLK) price target to $1,383 while maintaining Overweight, implying a 34% gain. The consensus remains Moderate Buy with an average target of $1,270.72. Diverging analyst revisions signal both caution and opportunity for the asset management giant.
Pentair’s revised Q2 2026 guidance stunned investors, with EPS of $1.12 against a $1.48 estimate and revenue of $930M, well below the $1.1B consensus. The stock slid to $75.74 on heavy volume, its 200-day MA, and the new full-year EPS range of $4.60-4.80 implies a 10-14% miss, triggering a fresh round of analyst target cuts.
Truckload rates hit 16% above baseline in Q2 2026, with a forecasted jump to 17.7% in Q3, as driver shortages and fuel costs squeeze capacity. Supply chain managers face crumbling routing guides and accelerating transportation expenses, demanding urgent strategic adjustments.
Wells Fargo lowered its price target on Freshpet to $70 from $75 while maintaining an Overweight rating, implying the stock is undervalued by 28%. The market remains skeptical with FRPT trading at $54.51, well below the consensus analyst target of $74.25. Analysts overall rate the pet food company a Moderate Buy, despite a string of recent target cuts.
Forgent Power Solutions draws a 'Moderate Buy' consensus from 13 analysts with an average price target of $55.36, implying 18% upside. Ten firms rate it a Buy or Outperform, driven by surging demand for data center electrical equipment and grid modernization.
A TD Cowen analysis suggests SpaceX might purchase T-Mobile to blend Starlink satellite coverage with terrestrial 5G, potentially upending the US wireless market and accelerating space-based connectivity integration.
Creek Drive Management Group initiates a $1.4 million position in EVLV, as institutional ownership reaches 66.65%. Large funds like Vanguard and State Street add to positions, and an analyst target of $10 highlights upside potential for the AI security firm.
United Airlines CEO Scott Kirby has signaled that ticket prices could rise by as much as 20% if jet fuel costs remain at current elevated levels. The warning highlights the growing pressure on airline margins as energy volatility threatens to disrupt travel demand and sector profitability.